CHAF1B and nasopharyngeal carcinoma: Consistent with our findings, previous studies have shown that an elevated CHAF1B level was closely associated with a poor prognosis of melanoma (22), prostate cancer (23), salivary gland tumors (24), nasopharyngeal carcinoma (25), breast cancer, and high-grade glioma (26, 27).